Gene · 8317
Papers1,550
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,550
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gene polymorphisms associated with progression of primary open-angle glaucoma: A systematic review. | Surv Ophthalmol | 2026 | 42754173 | PubTator, text mining | PubMed |
| Correction: Pauzaite et al. Dbf4-Cdc7 (DDK) Inhibitor PHA-767491 Displays Potent Anti-Proliferative Effects via Crosstalk with the CDK2-RB-E2F Pathway. Biomedicines 2022, 10, 2012. | Biomedicines | 2026 | 42652259 | PubTator, text mining | PubMed |
| CDC7 and APC/CCdh1 gate distinct routes to initiate DNA replication. | Nat Commun | 2026 | 42642404 | PubTator, text mining | PubMed |
| NCES: A Cell-Specific Network-Augmented Essentiality Framework for Cancer Therapeutic Target Discovery. | Comput Struct Biotechnol J | 2026 | 42491358 | PubTator, text mining | PubMed |
| Antitumor effects of the novel docetaxel derivative JJH201601 in glioma: targeting ribosome biogenesis and enhancing temozolomide sensitivity. | J Transl Med | 2026 | 42436511 | PubTator, text mining | PubMed |
| Design, Optimization and Mechanistic Insights Into Terpenoid-Derived Inhibitors of Protein Kinase C Iota. | Chem Biol Drug Des | 2026 | 42359997 | PubTator, text mining | PubMed |
| Exploring the multifaceted Dbf4-dependent kinase from temporal, spatial, and substrate repertoire perspectives. | Commun Biol | 2026 | 42337302 | PubTator, text mining | PubMed |
| Replication origin firing capacity indicates ATR inhibitor sensitivity. | Nat Commun | 2026 | 42321192 | PubTator, text mining | PubMed |
| EBNA1 inhibitors reveal CDC7 and POU2F1 as direct functional targets in EBV epithelial cancers. | mBio | 2026 | 42132380 | PubTator, text mining | PubMed |
| Predicting DNA replication-related protein expression at the nucleus level from HE: A deep learning study with same-specimen paired data. | Acta Histochem | 2026 | 42035593 | PubTator, text mining | PubMed |
| Cyclin E modulates vulnerability to CDC7 kinase inhibition. | Oncogenesis | 2026 | 42031714 | PubTator, text mining | PubMed |
| Mitotic error correction and the spindle assembly checkpoint: a tension-filled relationship. | Cell Cycle | 2026 | 41930946 | PubTator, text mining | PubMed |
| Genetic associations of variants in 10 glaucoma-related genes with POAG risk and structural phenotypes in Korean subjects. | Medicine (Baltimore) | 2026 | 41894275 | PubTator, text mining | PubMed |
| CHK1 is an integral regulator of DNA replication in human cells. | Cell Death Dis | 2026 | 41888112 | PubTator, text mining | PubMed |
| Palladium-Catalyzed Annulation of Acyl Saccharins with Norbornene via CO Shuttling. | Org Lett | 2026 | 41861365 | PubTator, text mining | PubMed |
| WDHD1 promotes hepatocellular carcinoma progression by affecting the cell cycle and immune evasion. | Transl Oncol | 2026 | 41850053 | PubTator, text mining | PubMed |
| Identification of Key Genes via Integrated Multi-Omics and Machine Learning Uncovers Tumor Biological Features and Prognostic Biomarkers in Uterine Leiomyosarcoma. | Int J Med Sci | 2026 | 41799759 | PubTator, text mining | PubMed |
| Next Generation DNA Damage Response Inhibitors: Harnessing Nanocarriers and Tumor Microenvironment for Precision Cancer Therapy. | Oncol Res | 2026 | 41799521 | PubTator, text mining | PubMed |
| TDP-43 phosphorylation: Exploring kinases, phosphatases, and therapeutic potential in neurodegeneration. | J Alzheimers Dis | 2026 | 41781371 | PubTator, text mining | PubMed |
| Identification of Key Genes Associated With Epithelial Barrier Dysfunction by Comprehensive Analysis and Experimental Validation. | Allergy | 2026 | 41755794 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8317/papers